Histoplasma mechanisms of pathogenesis - one portfolio doesn't fit all

FEMS Microbiology Letters

Volumn 324, Issue 1, 2011, Pages 1-9

  Edwards, Jessica A ^a   Rappleye, Chad A ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

glucan; Cbp1; Dimorphic fungi; Siderophore; Virulence determinants

Indexed keywords

ADHESIN; ALPHA GLUCAN; GLUCAN; IRON; PROTEIN CATB; PROTEIN CBP1; PROTEIN YPS3; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

FUNGAL GENETICS; FUNGAL GENOME; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS ISOLATION; GENE SEQUENCE; GENETIC VARIABILITY; HISTOPLASMA; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HOMEOSTASIS; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SHORT SURVEY;

ENDEMIC DISEASES; GENETIC VARIATION; HISTOPLASMA; HISTOPLASMOSIS; HUMANS; VIRULENCE FACTORS;

AJELLOMYCES; AJELLOMYCES CAPSULATUS; FUNGI;

EID: 80053519893     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2011.02363.x     Document Type: Short Survey

References (76)

1. Allen HL & Deepe GS Jr (2006) B cells and CD4-CD8- T cells are key regulators of the severity of reactivation histoplasmosis. J Immunol 177: 1763-1771.
2. Batanghari JW, Deepe GS Jr, Di Cera E & Goldman WE (1998) Histoplasma acquisition of calcium and expression of CBP1 during intracellular parasitism. Mol Microbiol 27: 531-539.
3. Beck MR, Dekoster GT, Cistola DP & Goldman WE (2009) NMR structure of a fungal virulence factor reveals structural homology with mammalian saposin B. Mol Microbiol 72: 344-353.
4. Bohse ML & Woods JP (2005) Surface localization of the Yps3p protein of Histoplasma capsulatum. Eukaryot Cell 4: 685-693.
5. Bohse ML & Woods JP (2007a) RNA interference-mediated silencing of the YPS3 gene of Histoplasma capsulatum reveals virulence defects. Infect Immun 75: 2811-2817.
6. Bohse ML & Woods JP (2007b) Expression and interstrain variability of the YPS3 gene of Histoplasma capsulatum. Eukaryot Cell 6: 609-615.
7. Bubnick M & Smulian AG (2007) The MAT1 locus of Histoplasma capsulatum is responsive in a mating type-specific manner. Eukaryot Cell 6: 616-621.
8. Cooper KG & Woods JP (2009) Secreted dipeptidyl peptidase IV activity in the dimorphic fungal pathogen Histoplasma capsulatum. Infect Immun 77: 2447-2454.
9. Domer JE (1971) Monosaccharide and chitin content of cell walls of Histoplasma capsulatum and Blastomyces dermatitidis. J Bacteriol 107: 870-877.
10. Durkin MM, Connolly PA, Karimi K et al. (2004) Pathogenic differences between North American and Latin American strains of Histoplasma capsulatum var. capsulatum in experimentally infected mice. J Clin Microbiol 42: 4370-4373.
11. Edwards LB, Acquaviva FA, Livesay VT, Cross FW & Palmer CE (1969) An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis 99(Suppl): 1-132.
12. Edwards JA, Alore EA & Rappleye CA (2011) The yeast-phase virulence requirement for {alpha}-glucan synthase differs among Histoplasma capsulatum chemotypes. Eukaryot Cell 10: 87-97.
13. Eissenberg LG, West JL, Woods JP & Goldman WE (1991) Infection of P388D1 macrophages and respiratory epithelial cells by Histoplasma capsulatum: selection of avirulent variants and their potential role in persistent histoplasmosis. Infect Immun 59: 1639-1646.
14. Eissenberg LG, Moser SA & Goldman WE (1997) Alterations to the cell wall of Histoplasma capsulatum yeasts during infection of macrophages or epithelial cells. J Infect Dis 175: 1538-1544.
15. Fisher KL, Deepe GS Jr & Woods JP (1999) Histoplasma capsulatum strain variation in both H antigen production and beta-glucosidase activity and overexpression of HAG1 from a telomeric linear plasmid. Infect Immun 67: 3312-3316.
16. Freifeld AG, Iwen PC, Lesiak BL, Gilroy RK, Stevens RB & Kalil AC (2005) Histoplasmosis in solid organ transplant recipients at a large Midwestern University Transplant Center. Transpl Infect Dis 7: 109-115.
17. Gaur PK & Lichtwardt RW (1980) Mating types and convertibility among soil isolates of Histoplasma capsulatum. Mycologia 72: 404-406.
18. Gomez FJ, Pilcher-Roberts R, Alborzi A & Newman SL (2008) Histoplasma capsulatum cyclophilin A mediates attachment to dendritic cell VLA-5. J Immunol 181: 7106-7114.
19. Goodwin TJ, Butler MI & Poulter RT (2003) Cryptons: a group of tyrosine-recombinase-encoding DNA transposons from pathogenic fungi. Microbiology 149: 3099-3109.
20. Guimaraes AJ, Hamilton AJ, de MGHL, Nosanchuk JD & Zancope-Oliveira RM (2008) Biological function and molecular mapping of M antigen in yeast phase of Histoplasma capsulatum. PLoS ONE 3: e3449.
21. Habich C, Kempe K, Gomez FJ et al. (2006) Heat shock protein 60: identification of specific epitopes for binding to primary macrophages. FEBS Lett 580: 115-120.
22. Hamilton AJ, Bartholomew MA, Figueroa J, Fenelon LE & Hay RJ (1990) Evidence that the M antigen of Histoplasma capsulatum var. capsulatum is a catalase which exhibits cross-reactivity with other dimorphic fungi. J Med Vet Mycol 28: 479-485.
23. Hilty J, Smulian AG & Newman SL (2008) The Histoplasma capsulatum vacuolar ATPase is required for iron homeostasis, intracellular replication in macrophages and virulence in a murine model of histoplasmosis. Mol Microbiol 70: 127-139.
24. Hilty J, George Smulian A & Newman SL (2011) Histoplasma capsulatum utilizes siderophores for intracellular iron acquisition in macrophages. Med Mycol 49: 633-642.
25. Holbrook ED, Edwards JA, Youseff BH & Rappleye CA (2011) Definition of the extracellular proteome of pathogenic-phase Histoplasma capsulatum. J Proteome Res 10: 1929-1943.
26. Hwang L, Hocking-Murray D, Bahrami AK, Andersson M, Rine J & Sil A (2003) Identifying phase-specific genes in the fungal pathogen Histoplasma capsulatum using a genomic shotgun microarray. Mol Biol Cell 14: 2314-2326.
27. Hwang LH, Mayfield JA, Rine J & Sil A (2008) Histoplasma requires SID1, a member of an iron-regulated siderophore gene cluster, for host colonization. PLoS Pathog 4: e1000044.
28. Jiang B, Bartlett MS, Allen SD, Smith JW, Wheat LJ, Connolly PA & Lee CH (2000) Typing of Histoplasma capsulatum isolates based on nucleotide sequence variation in the internal transcribed spacer regions of rRNA genes. J Clin Microbiol 38: 241-245.
29. Johnson CH, Klotz MG, York JL, Kruft V & McEwen JE (2002) Redundancy, phylogeny and differential expression of Histoplasma capsulatum catalases. Microbiology 148: 1129-1142.
30. Kanetsuna F, Carbonell LM, Gil F & Azuma I (1974) Chemical and ultrastructural studies on the cell walls of the yeastlike and mycelial forms of Histoplasma capsulatum. Mycopathol Mycol Appl 54: 1-13.
31. Karimi K, Wheat LJ, Connolly P et al. (2002) Differences in histoplasmosis in patients with acquired immunodeficiency syndrome in the United States and Brazil. J Infect Dis 186: 1655-1660.
32. Kasuga T, Taylor JW & White TJ (1999) Phylogenetic relationships of varieties and geographical groups of the human pathogenic fungus Histoplasma capsulatum Darling. J Clin Microbiol 37: 653-663.
33. Kasuga T, White TJ, Koenig G, et al. (2003) Phylogeography of the fungal pathogen Histoplasma capsulatum. Mol Ecol 12: 3383-3401.
34. Keath EJ, Painter AA, Kobayashi GS & Medoff G (1989) Variable expression of a yeast-phase-specific gene in Histoplasma capsulatum strains differing in thermotolerance and virulence. Infect Immun 57: 1384-1390.
35. Klimpel KR & Goldman WE (1987) Isolation and characterization of spontaneous avirulent variants of Histoplasma capsulatum. Infect Immun 55: 528-533.
36. Klimpel KR & Goldman WE (1988) Cell walls from avirulent variants of Histoplasma capsulatum lack alpha-(1, 3)-glucan. Infect Immun 56: 2997-3000.
37. Kugler S, Young B, Miller VL & Goldman WE (2000) Monitoring phase-specific gene expression in Histoplasma capsulatum with telomeric GFP fusion plasmids. Cell Microbiol 2: 537-547.
38. Kwon-Chung KJ (1973) Studies on Emmonsiella capsulata. I. Heterothallism and development of the ascocarp. Mycologia 65: 109-121.
39. Kwon-Chung KJ, Weeks RJ & Larsh HW (1974) Studies on Emmonsiella capsulata (Histoplasma capsulatum). II. Distribution of the two mating types in 13 endemic states of the United States. Am J Epidemiol 99: 44-49.
40. Kwon-Chung KJ, Bartlett MS & Wheat LJ (1984) Distribution of the two mating types among Histoplasma capsulatum isolates obtained from an urban histoplasmosis outbreak. Sabouraudia 22: 155-157.
41. Lane TE, Wu-Hsieh BA & Howard DH (1991) Iron limitation and the gamma interferon-mediated antihistoplasma state of murine macrophages. Infect Immun 59: 2274-2278.
42. Lee JH, Slifman NR, Gershon SK et al. (2002) Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept. Arthritis Rheum 46: 2565-2570.
43. Long KH, Gomez FJ, Morris RE & Newman SL (2003) Identification of heat shock protein 60 as the ligand on Histoplasma capsulatum that mediates binding to CD18 receptors on human macrophages. J Immunol 170: 487-494.
44. Marion CL, Rappleye CA, Engle JT & Goldman WE (2006) An alpha-(1, 4)-amylase is essential for alpha-(1, 3)-glucan production and virulence in Histoplasma capsulatum. Mol Microbiol 62: 970-983.
45. Mayfield JA & Rine J (2007) The genetic basis of variation in susceptibility to infection with Histoplasma capsulatum in the mouse. Genes Immun 8: 468-474.
46. McCormack FX, Gibbons R, Ward SR, Kuzmenko A, Wu H & Deepe GS Jr (2003) Macrophage-independent fungicidal action of the pulmonary collectins. J Biol Chem 278: 36250-36256.
47. McKinsey DS, Spiegel RA, Hutwagner L, et al. (1997) Prospective study of histoplasmosis in patients infected with human immunodeficiency virus: incidence, risk factors, and pathophysiology. Clin Infect Dis 24: 1195-1203.
48. Medoff G, Sacco M, Maresca B, Schlessinger D, Painter A, Kobayashi GS & Carratu L (1986) Irreversible block of the mycelial-to-yeast phase transition of Histoplasma capsulatum. Science 231: 476-479.
49. Nemecek JC, Wuthrich M & Klein BS (2006) Global control of dimorphism and virulence in fungi. Science 312: 583-588.
50. Newman SL (2001) Cell-mediated immunity to Histoplasma capsulatum. Semin Respir Infect 16: 102-108.
51. Newman SL, Gootee L, Brunner G & Deepe GS Jr (1994) Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis. J Clin Invest 93: 1422-1429.
52. Newman SL, Gootee L, Stroobant V, van der Goot H & Boelaert JR (1995) Inhibition of growth of Histoplasma capsulatum yeast cells in human macrophages by the iron chelator VUF 8514 and comparison of VUF 8514 with deferoxamine. Antimicrob Agents Chemother 39: 1824-1829.
53. Nguyen VQ & Sil A (2008) Temperature-induced switch to the pathogenic yeast form of Histoplasma capsulatum requires Ryp1, a conserved transcriptional regulator. P Natl Acad Sci USA 105: 4880-4885.
54. Nosanchuk JD, Gomez BL, Youngchim S et al. (2002) Histoplasma capsulatum synthesizes melanin-like pigments in vitro and during mammalian infection. Infect Immun 70: 5124-5131.
55. Nosanchuk JD, Steenbergen JN, Shi L, Deepe GS Jr & Casadevall A (2003) Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum. J Clin Invest 112: 1164-1175.
56. Rappleye CA, Engle JT & Goldman WE (2004) RNA interference in Histoplasma capsulatum demonstrates a role for alpha-(1, 3)-glucan in virulence. Mol Microbiol 53: 153-165.
57. Rappleye CA, Eissenberg LG & Goldman WE (2007) Histoplasma capsulatum alpha-(1, 3)-glucan blocks innate immune recognition by the beta-glucan receptor. P Natl Acad Sci USA 104: 1366-1370.
58. Reiss E (1977) Serial enzymatic hydrolysis of cell walls of two serotypes of yeast-form Histoplasma capsulatum with alpha(1 leads to 3)-glucanase, beta(1 leads to 3)-glucanase, pronase, and chitinase. Infect Immun 16: 181-188.
59. Reiss E, Miller SE, Kaplan W & Kaufman L (1977) Antigenic, chemical, and structural properties of cell walls of Histoplasma capsulatum yeast-form chemotypes 1 and 2 after serial enzymatic hydrolysis. Infect Immun 16: 690-700.
60. Rippon JW (1988) Histoplasmosis (Histoplasmosis casulati). Medical Mycology: the Pathogenic Fungi and the Pathogenic Actinomycetes, 3rd edn, pp. 381-423. W. B. Saunders Co., Philadelphia, PA.
61. Sebghati TS, Engle JT & Goldman WE (2000) Intracellular parasitism by Histoplasma capsulatum: fungal virulence and calcium dependence. Science 290: 1368-1372.
62. Spitzer ED, Keath EJ, Travis SJ, Painter AA, Kobayashi GS & Medoff G (1990) Temperature-sensitive variants of Histoplasma capsulatum isolated from patients with acquired immunodeficiency syndrome. J Infect Dis 162: 258-261.
63. Steele PE, Carle GF, Kobayashi GS & Medoff G (1989) Electrophoretic analysis of Histoplasma capsulatum chromosomal DNA. Mol Cell Biol 9: 983-987.
64. Tewari RP & Berkhout FJ (1972) Comparative pathogenicity of albino and brown types of Histoplasma capsulatum for mice. J Infect Dis 125: 504-508.
65. Tian X & Shearer G Jr (2002) The mold-specific MS8 gene is required for normal hypha formation in the dimorphic pathogenic fungus Histoplasma capsulatum. Eukaryot Cell 1: 249-256.
66. Timmerman MM & Woods JP (1999) Ferric reduction is a potential iron acquisition mechanism for Histoplasma capsulatum. Infect Immun 67: 6403-6408.
67. Timmerman MM & Woods JP (2001) Potential role for extracellular glutathione-dependent ferric reductase in utilization of environmental and host ferric compounds by Histoplasma capsulatum. Infect Immun 69: 7671-7678.
68. Webster RH & Sil A (2008) Conserved factors Ryp2 and Ryp3 control cell morphology and infectious spore formation in the fungal pathogen Histoplasma capsulatum. P Natl Acad Sci USA 105: 14573-14578.
69. Wheat LJ (1992) Histoplasmosis in Indianapolis. Clin Infect Dis 14(Suppl 1): S91-S99.
70. Wood KL, Hage CA, Knox KS et al. (2003) Histoplasmosis after treatment with anti-tumor necrosis factor-alpha therapy. Am J Respir Crit Care Med 167: 1279-1282.
71. Woods JP, Retallack DM, Heinecke EL & Goldman WE (1998) Rare homologous gene targeting in Histoplasma capsulatum: disruption of the URA5Hc gene by allelic replacement. J Bacteriol 180: 5135-5143.
72. Youseff BH, Dougherty JA & Rappleye CA (2009) Reverse genetics through random mutagenesis in Histoplasma capsulatum. BMC Microbiol 9: 236.
73. Zancope-Oliveira RM, Reiss E, Lott TJ, Mayer LW & Deepe GS Jr (1999) Molecular cloning, characterization, and expression of the M antigen of Histoplasma capsulatum. Infect Immun 67: 1947-1953.
74. Zarnowski R, Connolly PA, Wheat LJ & Woods JP (2007a) Production of extracellular proteolytic activity by Histoplasma capsulatum grown in Histoplasma-macrophage medium is limited to restriction fragment length polymorphism class 1 isolates. Diagn Microbiol Infect Dis 59: 39-47.
75. Zarnowski R, Miyazaki M, Dobrzyn A, Ntambi JM & Woods JP (2007b) Typing of Histoplasma capsulatum strains by fatty acid profile analysis. J Med Microbiol 56: 788-797.
76. Zarnowski R, Cooper KG, Brunold LS, Calaycay J & Woods JP (2008) Histoplasma capsulatum secreted gamma-glutamyltransferase reduces iron by generating an efficient ferric reductant. Mol Microbiol 70: 352-368.